nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Exemestane—breast cancer	0.21	0.591	CrCtD
Testolactone—Fluoxymesterone—breast cancer	0.146	0.409	CrCtD
Testolactone—CYP19A1—breast cancer	0.143	1	CbGaD
Testolactone—CYP19A1—Exemestane—breast cancer	0.0683	0.291	CbGbCtD
Testolactone—CYP19A1—Letrozole—breast cancer	0.0581	0.247	CbGbCtD
Testolactone—CYP19A1—Anastrozole—breast cancer	0.0518	0.22	CbGbCtD
Testolactone—CYP19A1—Raloxifene—breast cancer	0.0262	0.111	CbGbCtD
Testolactone—Formestane—Exemestane—breast cancer	0.0178	0.0827	CrCrCtD
Testolactone—CYP19A1—Tamoxifen—breast cancer	0.0173	0.0736	CbGbCtD
Testolactone—Estrone—Exemestane—breast cancer	0.0169	0.0785	CrCrCtD
Testolactone—Dydrogesterone—Exemestane—breast cancer	0.0169	0.0785	CrCrCtD
Testolactone—CYP19A1—Paclitaxel—breast cancer	0.0135	0.0573	CbGbCtD
Testolactone—Dydrogesterone—Fluoxymesterone—breast cancer	0.0117	0.0544	CrCrCtD
Testolactone—Spironolactone—Fluoxymesterone—breast cancer	0.0112	0.0519	CrCrCtD
Testolactone—Prednisone—Exemestane—breast cancer	0.00995	0.0463	CrCrCtD
Testolactone—Danazol—Fluoxymesterone—breast cancer	0.00942	0.0438	CrCrCtD
Testolactone—Fluprednidene Acetate—Exemestane—breast cancer	0.00924	0.043	CrCrCtD
Testolactone—Loteprednol—Exemestane—breast cancer	0.00924	0.043	CrCrCtD
Testolactone—Methylprednisolone—Exemestane—breast cancer	0.00864	0.0402	CrCrCtD
Testolactone—Testosterone—Exemestane—breast cancer	0.00864	0.0402	CrCrCtD
Testolactone—Prednisolone—Exemestane—breast cancer	0.00846	0.0393	CrCrCtD
Testolactone—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0069	0.0321	CrCrCtD
Testolactone—Progesterone—Fluoxymesterone—breast cancer	0.0069	0.0321	CrCrCtD
Testolactone—Methyltestosterone—Fluoxymesterone—breast cancer	0.00673	0.0313	CrCrCtD
Testolactone—Desoximetasone—Fluoxymesterone—breast cancer	0.00656	0.0305	CrCrCtD
Testolactone—Mometasone—Fluoxymesterone—breast cancer	0.00641	0.0298	CrCrCtD
Testolactone—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.00641	0.0298	CrCrCtD
Testolactone—Loteprednol—Fluoxymesterone—breast cancer	0.00641	0.0298	CrCrCtD
Testolactone—Triamcinolone—Fluoxymesterone—breast cancer	0.00641	0.0298	CrCrCtD
Testolactone—Dexamethasone—Fluoxymesterone—breast cancer	0.00626	0.0291	CrCrCtD
Testolactone—Betamethasone—Fluoxymesterone—breast cancer	0.00626	0.0291	CrCrCtD
Testolactone—CYP19A1—corpus luteum—breast cancer	0.00599	0.669	CbGeAlD
Testolactone—Testosterone—Fluoxymesterone—breast cancer	0.00599	0.0278	CrCrCtD
Testolactone—Prednisolone—Fluoxymesterone—breast cancer	0.00586	0.0273	CrCrCtD
Testolactone—CYP19A1—endometrium—breast cancer	0.000464	0.0517	CbGeAlD
Testolactone—CYP19A1—uterus—breast cancer	0.000427	0.0477	CbGeAlD
Testolactone—CYP19A1—adipose tissue—breast cancer	0.000418	0.0466	CbGeAlD
Testolactone—CYP19A1—female reproductive system—breast cancer	0.000384	0.0429	CbGeAlD
Testolactone—CYP19A1—adrenal gland—breast cancer	0.000375	0.0418	CbGeAlD
Testolactone—CYP19A1—female gonad—breast cancer	0.000349	0.039	CbGeAlD
Testolactone—CYP19A1—endocrine gland—breast cancer	0.000325	0.0363	CbGeAlD
Testolactone—CYP19A1—FSH signaling pathway—RPS6KB2—breast cancer	0.000278	0.0228	CbGpPWpGaD
Testolactone—CYP19A1—Tryptophan metabolism—ALDH1A1—breast cancer	0.000234	0.0192	CbGpPWpGaD
Testolactone—CYP19A1—Endogenous sterols—CYP17A1—breast cancer	0.000227	0.0186	CbGpPWpGaD
Testolactone—CYP19A1—lymph node—breast cancer	0.000225	0.0251	CbGeAlD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RAD54L—breast cancer	0.000218	0.0179	CbGpPWpGaD
Testolactone—Fluoxymesterone—PRLR—breast cancer	0.000217	0.111	CrCbGaD
Testolactone—CYP19A1—Endogenous sterols—NCOA2—breast cancer	0.000216	0.0177	CbGpPWpGaD
Testolactone—CYP19A1—Endogenous sterols—CYP1B1—breast cancer	0.000191	0.0156	CbGpPWpGaD
Testolactone—Oedema—Exemestane—breast cancer	0.000189	0.00665	CcSEcCtD
Testolactone—Decreased appetite—Toremifene—breast cancer	0.000187	0.00657	CcSEcCtD
Testolactone—Pain—Fulvestrant—breast cancer	0.000186	0.00655	CcSEcCtD
Testolactone—Malaise—Anastrozole—breast cancer	0.000186	0.00653	CcSEcCtD
Testolactone—Malaise—Letrozole—breast cancer	0.000186	0.00653	CcSEcCtD
Testolactone—Blood pressure increased—Paclitaxel—breast cancer	0.000185	0.00652	CcSEcCtD
Testolactone—Pain—Toremifene—breast cancer	0.000184	0.00646	CcSEcCtD
Testolactone—CYP19A1—Endogenous sterols—NCOA1—breast cancer	0.000182	0.0149	CbGpPWpGaD
Testolactone—Anorexia—Exemestane—breast cancer	0.00018	0.00634	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—RPS6—breast cancer	0.000179	0.0147	CbGpPWpGaD
Testolactone—Oedema—Ixabepilone—breast cancer	0.000178	0.00628	CcSEcCtD
Testolactone—Discomfort—Anastrozole—breast cancer	0.000173	0.00609	CcSEcCtD
Testolactone—Discomfort—Letrozole—breast cancer	0.000173	0.00609	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—PGR—breast cancer	0.000172	0.0141	CbGpPWpGaD
Testolactone—Anorexia—Ixabepilone—breast cancer	0.00017	0.00598	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—breast cancer	0.00017	0.0139	CbGpPWpGaD
Testolactone—Paraesthesia—Exemestane—breast cancer	0.00017	0.00597	CcSEcCtD
Testolactone—Oedema—Anastrozole—breast cancer	0.000168	0.00591	CcSEcCtD
Testolactone—Oedema—Letrozole—breast cancer	0.000168	0.00591	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PHB—breast cancer	0.000165	0.0135	CbGpPWpGaD
Testolactone—Decreased appetite—Exemestane—breast cancer	0.000164	0.00578	CcSEcCtD
Testolactone—Pain—Exemestane—breast cancer	0.000162	0.00569	CcSEcCtD
Testolactone—Alopecia—Chlorambucil—breast cancer	0.000161	0.00565	CcSEcCtD
Testolactone—Paraesthesia—Ixabepilone—breast cancer	0.00016	0.00564	CcSEcCtD
Testolactone—Anorexia—Anastrozole—breast cancer	0.00016	0.00563	CcSEcCtD
Testolactone—Anorexia—Letrozole—breast cancer	0.00016	0.00563	CcSEcCtD
Testolactone—Blood pressure increased—Docetaxel—breast cancer	0.000157	0.00553	CcSEcCtD
Testolactone—Feeling abnormal—Exemestane—breast cancer	0.000156	0.00548	CcSEcCtD
Testolactone—Decreased appetite—Ixabepilone—breast cancer	0.000155	0.00546	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000153	0.0126	CbGpPWpGaD
Testolactone—Pain—Ixabepilone—breast cancer	0.000153	0.00537	CcSEcCtD
Testolactone—Blood pressure increased—Capecitabine—breast cancer	0.000152	0.00535	CcSEcCtD
Testolactone—Anorexia—Idarubicin—breast cancer	0.000152	0.00535	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—ESR2—breast cancer	0.000152	0.0124	CbGpPWpGaD
Testolactone—Paraesthesia—Letrozole—breast cancer	0.000151	0.00531	CcSEcCtD
Testolactone—Paraesthesia—Anastrozole—breast cancer	0.000151	0.00531	CcSEcCtD
Testolactone—Vomiting—Lapatinib—breast cancer	0.00015	0.00529	CcSEcCtD
Testolactone—Alopecia—Vinblastine—breast cancer	0.000147	0.00518	CcSEcCtD
Testolactone—Decreased appetite—Anastrozole—breast cancer	0.000146	0.00514	CcSEcCtD
Testolactone—Decreased appetite—Letrozole—breast cancer	0.000146	0.00514	CcSEcCtD
Testolactone—Pain—Anastrozole—breast cancer	0.000144	0.00505	CcSEcCtD
Testolactone—Pain—Letrozole—breast cancer	0.000144	0.00505	CcSEcCtD
Testolactone—Alopecia—Tamoxifen—breast cancer	0.000143	0.00503	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—EGR1—breast cancer	0.000142	0.0116	CbGpPWpGaD
Testolactone—Erythema—Tamoxifen—breast cancer	0.000141	0.00496	CcSEcCtD
Testolactone—Nausea—Lapatinib—breast cancer	0.000141	0.00495	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ARAF—breast cancer	0.00014	0.0115	CbGpPWpGaD
Testolactone—Alopecia—Melphalan—breast cancer	0.00014	0.00493	CcSEcCtD
Testolactone—Decreased appetite—Idarubicin—breast cancer	0.000139	0.00488	CcSEcCtD
Testolactone—Feeling abnormal—Anastrozole—breast cancer	0.000138	0.00487	CcSEcCtD
Testolactone—Feeling abnormal—Letrozole—breast cancer	0.000138	0.00487	CcSEcCtD
Testolactone—Vomiting—Fulvestrant—breast cancer	0.000138	0.00487	CcSEcCtD
Testolactone—Vomiting—Toremifene—breast cancer	0.000137	0.00481	CcSEcCtD
Testolactone—Alopecia—Goserelin—breast cancer	0.000137	0.0048	CcSEcCtD
Testolactone—Pain—Raloxifene—breast cancer	0.000136	0.0048	CcSEcCtD
Testolactone—Erythema—Goserelin—breast cancer	0.000135	0.00473	CcSEcCtD
Testolactone—Ill-defined disorder—Vinblastine—breast cancer	0.000135	0.00473	CcSEcCtD
Testolactone—Malaise—Vinblastine—breast cancer	0.000131	0.0046	CcSEcCtD
Testolactone—Nausea—Fulvestrant—breast cancer	0.000129	0.00455	CcSEcCtD
Testolactone—Nausea—Toremifene—breast cancer	0.000128	0.00449	CcSEcCtD
Testolactone—Ill-defined disorder—Goserelin—breast cancer	0.000125	0.00439	CcSEcCtD
Testolactone—Anorexia—Chlorambucil—breast cancer	0.000123	0.00433	CcSEcCtD
Testolactone—Glossitis—Methotrexate—breast cancer	0.000123	0.00432	CcSEcCtD
Testolactone—Alopecia—Vinorelbine—breast cancer	0.000122	0.0043	CcSEcCtD
Testolactone—Discomfort—Vinblastine—breast cancer	0.000122	0.00429	CcSEcCtD
Testolactone—Malaise—Goserelin—breast cancer	0.000121	0.00427	CcSEcCtD
Testolactone—Erythema—Vinorelbine—breast cancer	0.00012	0.00424	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—VDR—breast cancer	0.00012	0.00987	CbGpPWpGaD
Testolactone—Vomiting—Exemestane—breast cancer	0.00012	0.00423	CcSEcCtD
Testolactone—Discomfort—Tamoxifen—breast cancer	0.000118	0.00417	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CHST9—breast cancer	0.000117	0.00961	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—NCOR1—breast cancer	0.000117	0.0096	CbGpPWpGaD
Testolactone—Alopecia—Thiotepa—breast cancer	0.000117	0.00411	CcSEcCtD
Testolactone—Erythema—Thiotepa—breast cancer	0.000115	0.00405	CcSEcCtD
Testolactone—Glossitis—Epirubicin—breast cancer	0.000115	0.00405	CcSEcCtD
Testolactone—Oedema—Tamoxifen—breast cancer	0.000115	0.00404	CcSEcCtD
Testolactone—Vomiting—Ixabepilone—breast cancer	0.000113	0.00399	CcSEcCtD
Testolactone—Discomfort—Goserelin—breast cancer	0.000113	0.00398	CcSEcCtD
Testolactone—Anorexia—Vinblastine—breast cancer	0.000113	0.00397	CcSEcCtD
Testolactone—Oedema—Melphalan—breast cancer	0.000113	0.00396	CcSEcCtD
Testolactone—Nausea—Exemestane—breast cancer	0.000112	0.00395	CcSEcCtD
Testolactone—Decreased appetite—Chlorambucil—breast cancer	0.000112	0.00395	CcSEcCtD
Testolactone—Ill-defined disorder—Vinorelbine—breast cancer	0.000112	0.00393	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP3A4—breast cancer	0.000111	0.00914	CbGpPWpGaD
Testolactone—Pain—Chlorambucil—breast cancer	0.00011	0.00389	CcSEcCtD
Testolactone—Oedema—Goserelin—breast cancer	0.00011	0.00386	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP1B1—breast cancer	0.00011	0.00898	CbGpPWpGaD
Testolactone—Anorexia—Tamoxifen—breast cancer	0.00011	0.00386	CcSEcCtD
Testolactone—Malaise—Vinorelbine—breast cancer	0.000109	0.00382	CcSEcCtD
Testolactone—Anorexia—Melphalan—breast cancer	0.000107	0.00377	CcSEcCtD
Testolactone—Vomiting—Anastrozole—breast cancer	0.000107	0.00376	CcSEcCtD
Testolactone—Vomiting—Letrozole—breast cancer	0.000107	0.00376	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—breast cancer	0.000106	0.00374	CcSEcCtD
Testolactone—Feeling abnormal—Chlorambucil—breast cancer	0.000106	0.00374	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BARD1—breast cancer	0.000106	0.00872	CbGpPWpGaD
Testolactone—Paraesthesia—Vinblastine—breast cancer	0.000106	0.00374	CcSEcCtD
Testolactone—Nausea—Ixabepilone—breast cancer	0.000106	0.00373	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	0.000105	0.00863	CbGpPWpGaD
Testolactone—Anorexia—Goserelin—breast cancer	0.000105	0.00368	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—breast cancer	0.000104	0.00851	CbGpPWpGaD
Testolactone—Paraesthesia—Tamoxifen—breast cancer	0.000103	0.00363	CcSEcCtD
Testolactone—Decreased appetite—Vinblastine—breast cancer	0.000103	0.00362	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	0.000102	0.00838	CbGpPWpGaD
Testolactone—Vomiting—Raloxifene—breast cancer	0.000101	0.00357	CcSEcCtD
Testolactone—Vomiting—Idarubicin—breast cancer	0.000101	0.00357	CcSEcCtD
Testolactone—Discomfort—Vinorelbine—breast cancer	0.000101	0.00357	CcSEcCtD
Testolactone—Pain—Vinblastine—breast cancer	0.000101	0.00356	CcSEcCtD
Testolactone—Paraesthesia—Melphalan—breast cancer	0.000101	0.00356	CcSEcCtD
Testolactone—Alopecia—Irinotecan—breast cancer	0.000101	0.00355	CcSEcCtD
Testolactone—Alopecia—Mitoxantrone—breast cancer	0.000101	0.00355	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—breast cancer	0.000101	0.00827	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	0.0001	0.00822	CbGpPWpGaD
Testolactone—Decreased appetite—Tamoxifen—breast cancer	9.99e-05	0.00352	CcSEcCtD
Testolactone—Nausea—Anastrozole—breast cancer	9.98e-05	0.00351	CcSEcCtD
Testolactone—Nausea—Letrozole—breast cancer	9.98e-05	0.00351	CcSEcCtD
Testolactone—Erythema—Mitoxantrone—breast cancer	9.94e-05	0.0035	CcSEcCtD
Testolactone—Paraesthesia—Goserelin—breast cancer	9.86e-05	0.00347	CcSEcCtD
Testolactone—Pain—Tamoxifen—breast cancer	9.83e-05	0.00346	CcSEcCtD
Testolactone—Alopecia—Gemcitabine—breast cancer	9.83e-05	0.00346	CcSEcCtD
Testolactone—Decreased appetite—Melphalan—breast cancer	9.78e-05	0.00344	CcSEcCtD
Testolactone—Feeling abnormal—Vinblastine—breast cancer	9.75e-05	0.00343	CcSEcCtD
Testolactone—Erythema—Gemcitabine—breast cancer	9.68e-05	0.00341	CcSEcCtD
Testolactone—Alopecia—Fluorouracil—breast cancer	9.66e-05	0.0034	CcSEcCtD
Testolactone—Pain—Melphalan—breast cancer	9.63e-05	0.00339	CcSEcCtD
Testolactone—Decreased appetite—Goserelin—breast cancer	9.54e-05	0.00336	CcSEcCtD
Testolactone—Erythema—Fluorouracil—breast cancer	9.52e-05	0.00335	CcSEcCtD
Testolactone—Nausea—Idarubicin—breast cancer	9.47e-05	0.00333	CcSEcCtD
Testolactone—Nausea—Raloxifene—breast cancer	9.47e-05	0.00333	CcSEcCtD
Testolactone—Dydrogesterone—PGR—breast cancer	9.39e-05	0.0479	CrCbGaD
Testolactone—Pain—Goserelin—breast cancer	9.39e-05	0.0033	CcSEcCtD
Testolactone—Anorexia—Vinorelbine—breast cancer	9.37e-05	0.0033	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—ATM—breast cancer	9.28e-05	0.0076	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—CDK4—breast cancer	9.24e-05	0.00757	CbGpPWpGaD
Testolactone—Ill-defined disorder—Irinotecan—breast cancer	9.22e-05	0.00324	CcSEcCtD
Testolactone—Ill-defined disorder—Mitoxantrone—breast cancer	9.22e-05	0.00324	CcSEcCtD
Testolactone—Feeling abnormal—Goserelin—breast cancer	9.05e-05	0.00318	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—breast cancer	9.05e-05	0.00741	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—XRCC3—breast cancer	9.05e-05	0.00741	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BMPR2—breast cancer	9.05e-05	0.00741	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—breast cancer	9.01e-05	0.00739	CbGpPWpGaD
Testolactone—Ill-defined disorder—Gemcitabine—breast cancer	8.98e-05	0.00316	CcSEcCtD
Testolactone—Malaise—Mitoxantrone—breast cancer	8.96e-05	0.00315	CcSEcCtD
Testolactone—Malaise—Irinotecan—breast cancer	8.96e-05	0.00315	CcSEcCtD
Testolactone—Anorexia—Thiotepa—breast cancer	8.95e-05	0.00315	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—breast cancer	8.9e-05	0.00729	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	8.86e-05	0.00726	CbGpPWpGaD
Testolactone—Paraesthesia—Vinorelbine—breast cancer	8.83e-05	0.00311	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—breast cancer	8.75e-05	0.00717	CbGpPWpGaD
Testolactone—Malaise—Gemcitabine—breast cancer	8.73e-05	0.00307	CcSEcCtD
Testolactone—Decreased appetite—Vinorelbine—breast cancer	8.55e-05	0.00301	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	8.53e-05	0.00699	CbGpPWpGaD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	8.45e-05	0.00693	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	8.45e-05	0.00692	CbGpPWpGaD
Testolactone—Paraesthesia—Thiotepa—breast cancer	8.43e-05	0.00297	CcSEcCtD
Testolactone—Pain—Vinorelbine—breast cancer	8.41e-05	0.00296	CcSEcCtD
Testolactone—Discomfort—Mitoxantrone—breast cancer	8.36e-05	0.00294	CcSEcCtD
Testolactone—Discomfort—Irinotecan—breast cancer	8.36e-05	0.00294	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—CYP1A1—breast cancer	8.31e-05	0.00681	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	8.29e-05	0.00679	CbGpPWpGaD
Testolactone—Alopecia—Paclitaxel—breast cancer	8.23e-05	0.00289	CcSEcCtD
Testolactone—Vomiting—Chlorambucil—breast cancer	8.21e-05	0.00289	CcSEcCtD
Testolactone—Decreased appetite—Thiotepa—breast cancer	8.16e-05	0.00287	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—ALDH1A1—breast cancer	8.15e-05	0.00668	CbGpPWpGaD
Testolactone—Discomfort—Gemcitabine—breast cancer	8.14e-05	0.00286	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	8.13e-05	0.00667	CbGpPWpGaD
Testolactone—Oedema—Mitoxantrone—breast cancer	8.11e-05	0.00285	CcSEcCtD
Testolactone—Oedema—Irinotecan—breast cancer	8.11e-05	0.00285	CcSEcCtD
Testolactone—Erythema—Paclitaxel—breast cancer	8.1e-05	0.00285	CcSEcCtD
Testolactone—Feeling abnormal—Vinorelbine—breast cancer	8.1e-05	0.00285	CcSEcCtD
Testolactone—Pain—Thiotepa—breast cancer	8.03e-05	0.00283	CcSEcCtD
Testolactone—Discomfort—Fluorouracil—breast cancer	8.01e-05	0.00282	CcSEcCtD
Testolactone—Oedema—Gemcitabine—breast cancer	7.9e-05	0.00278	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—RAF1—breast cancer	7.82e-05	0.00641	CbGpPWpGaD
Testolactone—Oedema—Fluorouracil—breast cancer	7.77e-05	0.00273	CcSEcCtD
Testolactone—Feeling abnormal—Thiotepa—breast cancer	7.74e-05	0.00272	CcSEcCtD
Testolactone—Anorexia—Mitoxantrone—breast cancer	7.73e-05	0.00272	CcSEcCtD
Testolactone—Anorexia—Irinotecan—breast cancer	7.73e-05	0.00272	CcSEcCtD
Testolactone—Nausea—Chlorambucil—breast cancer	7.67e-05	0.0027	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—MTOR—breast cancer	7.64e-05	0.00626	CbGpPWpGaD
Testolactone—Anorexia—Gemcitabine—breast cancer	7.53e-05	0.00265	CcSEcCtD
Testolactone—Vomiting—Vinblastine—breast cancer	7.52e-05	0.00265	CcSEcCtD
Testolactone—Ill-defined disorder—Paclitaxel—breast cancer	7.52e-05	0.00265	CcSEcCtD
Testolactone—Anorexia—Fluorouracil—breast cancer	7.4e-05	0.00261	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MRE11A—breast cancer	7.37e-05	0.00604	CbGpPWpGaD
Testolactone—Vomiting—Tamoxifen—breast cancer	7.31e-05	0.00257	CcSEcCtD
Testolactone—Malaise—Paclitaxel—breast cancer	7.31e-05	0.00257	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	7.31e-05	0.00599	CbGpPWpGaD
Testolactone—Paraesthesia—Irinotecan—breast cancer	7.28e-05	0.00256	CcSEcCtD
Testolactone—Paraesthesia—Mitoxantrone—breast cancer	7.28e-05	0.00256	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA3—breast cancer	7.26e-05	0.00595	CbGpPWpGaD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	7.18e-05	0.00589	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA3—breast cancer	7.16e-05	0.00587	CbGpPWpGaD
Testolactone—Vomiting—Melphalan—breast cancer	7.16e-05	0.00252	CcSEcCtD
Testolactone—Paraesthesia—Gemcitabine—breast cancer	7.09e-05	0.0025	CcSEcCtD
Testolactone—Decreased appetite—Mitoxantrone—breast cancer	7.05e-05	0.00248	CcSEcCtD
Testolactone—Decreased appetite—Irinotecan—breast cancer	7.05e-05	0.00248	CcSEcCtD
Testolactone—Nausea—Vinblastine—breast cancer	7.03e-05	0.00247	CcSEcCtD
Testolactone—Vomiting—Goserelin—breast cancer	6.98e-05	0.00246	CcSEcCtD
Testolactone—Paraesthesia—Fluorouracil—breast cancer	6.97e-05	0.00245	CcSEcCtD
Testolactone—Alopecia—Docetaxel—breast cancer	6.97e-05	0.00245	CcSEcCtD
Testolactone—Pain—Irinotecan—breast cancer	6.94e-05	0.00244	CcSEcCtD
Testolactone—Pain—Mitoxantrone—breast cancer	6.94e-05	0.00244	CcSEcCtD
Testolactone—Erythema—Docetaxel—breast cancer	6.87e-05	0.00242	CcSEcCtD
Testolactone—Decreased appetite—Gemcitabine—breast cancer	6.87e-05	0.00242	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	6.85e-05	0.00562	CbGpPWpGaD
Testolactone—Nausea—Tamoxifen—breast cancer	6.83e-05	0.0024	CcSEcCtD
Testolactone—Discomfort—Paclitaxel—breast cancer	6.82e-05	0.0024	CcSEcCtD
Testolactone—Pain—Gemcitabine—breast cancer	6.76e-05	0.00238	CcSEcCtD
Testolactone—Decreased appetite—Fluorouracil—breast cancer	6.75e-05	0.00238	CcSEcCtD
Testolactone—Alopecia—Capecitabine—breast cancer	6.75e-05	0.00238	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	6.72e-05	0.0055	CbGpPWpGaD
Testolactone—Nausea—Melphalan—breast cancer	6.69e-05	0.00235	CcSEcCtD
Testolactone—Feeling abnormal—Irinotecan—breast cancer	6.68e-05	0.00235	CcSEcCtD
Testolactone—Feeling abnormal—Mitoxantrone—breast cancer	6.68e-05	0.00235	CcSEcCtD
Testolactone—Erythema—Capecitabine—breast cancer	6.65e-05	0.00234	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA4—breast cancer	6.64e-05	0.00545	CbGpPWpGaD
Testolactone—Pain—Fluorouracil—breast cancer	6.64e-05	0.00234	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—breast cancer	6.63e-05	0.00543	CbGpPWpGaD
Testolactone—Oedema—Paclitaxel—breast cancer	6.61e-05	0.00233	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GSTA4—breast cancer	6.55e-05	0.00537	CbGpPWpGaD
Testolactone—Nausea—Goserelin—breast cancer	6.52e-05	0.00229	CcSEcCtD
Testolactone—Feeling abnormal—Gemcitabine—breast cancer	6.51e-05	0.00229	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA2—breast cancer	6.47e-05	0.00531	CbGpPWpGaD
Testolactone—Feeling abnormal—Fluorouracil—breast cancer	6.4e-05	0.00225	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—SULT1A1—breast cancer	6.4e-05	0.00524	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GPX2—breast cancer	6.39e-05	0.00523	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—SULT1A1—breast cancer	6.31e-05	0.00517	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GPX4—breast cancer	6.31e-05	0.00517	CbGpPWpGaD
Testolactone—Anorexia—Paclitaxel—breast cancer	6.3e-05	0.00222	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AHR—breast cancer	6.27e-05	0.00514	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—CDKN1B—breast cancer	6.25e-05	0.00513	CbGpPWpGaD
Testolactone—Vomiting—Vinorelbine—breast cancer	6.25e-05	0.0022	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTA1—breast cancer	6.25e-05	0.00512	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—NAT2—breast cancer	6.18e-05	0.00506	CbGpPWpGaD
Testolactone—Ill-defined disorder—Capecitabine—breast cancer	6.17e-05	0.00217	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—SRC—breast cancer	6.12e-05	0.00501	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—NAT2—breast cancer	6.09e-05	0.00499	CbGpPWpGaD
Testolactone—Malaise—Capecitabine—breast cancer	6e-05	0.00211	CcSEcCtD
Testolactone—Vomiting—Thiotepa—breast cancer	5.97e-05	0.0021	CcSEcCtD
Testolactone—Paraesthesia—Paclitaxel—breast cancer	5.94e-05	0.00209	CcSEcCtD
Testolactone—Nausea—Vinorelbine—breast cancer	5.84e-05	0.00206	CcSEcCtD
Testolactone—Decreased appetite—Paclitaxel—breast cancer	5.75e-05	0.00202	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—breast cancer	5.74e-05	0.00471	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RAD51—breast cancer	5.7e-05	0.00467	CbGpPWpGaD
Testolactone—Pain—Paclitaxel—breast cancer	5.66e-05	0.00199	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—MAPK3—breast cancer	5.64e-05	0.00462	CbGpPWpGaD
Testolactone—Oedema—Docetaxel—breast cancer	5.61e-05	0.00197	CcSEcCtD
Testolactone—Discomfort—Capecitabine—breast cancer	5.59e-05	0.00197	CcSEcCtD
Testolactone—Testosterone Propionate—CYP17A1—breast cancer	5.58e-05	0.0285	CrCbGaD
Testolactone—Nausea—Thiotepa—breast cancer	5.58e-05	0.00196	CcSEcCtD
Testolactone—Exemestane—CYP19A1—breast cancer	5.48e-05	0.0279	CrCbGaD
Testolactone—Feeling abnormal—Paclitaxel—breast cancer	5.45e-05	0.00192	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	5.44e-05	0.00446	CbGpPWpGaD
Testolactone—Oedema—Capecitabine—breast cancer	5.43e-05	0.00191	CcSEcCtD
Testolactone—Anorexia—Docetaxel—breast cancer	5.34e-05	0.00188	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	5.22e-05	0.00428	CbGpPWpGaD
Testolactone—Anorexia—Capecitabine—breast cancer	5.17e-05	0.00182	CcSEcCtD
Testolactone—Vomiting—Mitoxantrone—breast cancer	5.16e-05	0.00181	CcSEcCtD
Testolactone—Vomiting—Irinotecan—breast cancer	5.16e-05	0.00181	CcSEcCtD
Testolactone—CYP19A1—Tryptophan metabolism—MDM2—breast cancer	5.12e-05	0.0042	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—MTR—breast cancer	5.04e-05	0.00413	CbGpPWpGaD
Testolactone—Paraesthesia—Docetaxel—breast cancer	5.03e-05	0.00177	CcSEcCtD
Testolactone—Alopecia—Methotrexate—breast cancer	5.03e-05	0.00177	CcSEcCtD
Testolactone—Vomiting—Gemcitabine—breast cancer	5.02e-05	0.00177	CcSEcCtD
Testolactone—Erythema—Methotrexate—breast cancer	4.95e-05	0.00174	CcSEcCtD
Testolactone—Vomiting—Fluorouracil—breast cancer	4.94e-05	0.00174	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—HPGDS—breast cancer	4.94e-05	0.00405	CbGpPWpGaD
Testolactone—Drospirenone—PGR—breast cancer	4.94e-05	0.0252	CrCbGaD
Testolactone—Paraesthesia—Capecitabine—breast cancer	4.87e-05	0.00171	CcSEcCtD
Testolactone—Decreased appetite—Docetaxel—breast cancer	4.87e-05	0.00171	CcSEcCtD
Testolactone—Nausea—Irinotecan—breast cancer	4.82e-05	0.00169	CcSEcCtD
Testolactone—Nausea—Mitoxantrone—breast cancer	4.82e-05	0.00169	CcSEcCtD
Testolactone—Pain—Docetaxel—breast cancer	4.79e-05	0.00169	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTT1—breast cancer	4.79e-05	0.00393	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AURKA—breast cancer	4.75e-05	0.00389	CbGpPWpGaD
Testolactone—Decreased appetite—Capecitabine—breast cancer	4.72e-05	0.00166	CcSEcCtD
Testolactone—Alopecia—Epirubicin—breast cancer	4.7e-05	0.00165	CcSEcCtD
Testolactone—Nausea—Gemcitabine—breast cancer	4.69e-05	0.00165	CcSEcCtD
Testolactone—Pain—Capecitabine—breast cancer	4.64e-05	0.00163	CcSEcCtD
Testolactone—Erythema—Epirubicin—breast cancer	4.63e-05	0.00163	CcSEcCtD
Testolactone—Feeling abnormal—Docetaxel—breast cancer	4.62e-05	0.00163	CcSEcCtD
Testolactone—Nausea—Fluorouracil—breast cancer	4.61e-05	0.00162	CcSEcCtD
Testolactone—Ill-defined disorder—Methotrexate—breast cancer	4.59e-05	0.00162	CcSEcCtD
Testolactone—Testosterone Propionate—COMT—breast cancer	4.55e-05	0.0232	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP17A1—breast cancer	4.53e-05	0.00372	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—PTGS1—breast cancer	4.49e-05	0.00368	CbGpPWpGaD
Testolactone—Feeling abnormal—Capecitabine—breast cancer	4.47e-05	0.00157	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP17A1—breast cancer	4.47e-05	0.00366	CbGpPWpGaD
Testolactone—Malaise—Methotrexate—breast cancer	4.46e-05	0.00157	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP2D6—breast cancer	4.4e-05	0.00361	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PAK1—breast cancer	4.38e-05	0.00359	CbGpPWpGaD
Testolactone—Estrone—SLCO1B1—breast cancer	4.38e-05	0.0223	CrCbGaD
Testolactone—Alopecia—Doxorubicin—breast cancer	4.35e-05	0.00153	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP2D6—breast cancer	4.34e-05	0.00356	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—NCOA2—breast cancer	4.32e-05	0.00354	CbGpPWpGaD
Testolactone—Ill-defined disorder—Epirubicin—breast cancer	4.3e-05	0.00151	CcSEcCtD
Testolactone—Erythema—Doxorubicin—breast cancer	4.29e-05	0.00151	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—breast cancer	4.25e-05	0.00348	CbGpPWpGaD
Testolactone—Vomiting—Paclitaxel—breast cancer	4.21e-05	0.00148	CcSEcCtD
Testolactone—Malaise—Epirubicin—breast cancer	4.18e-05	0.00147	CcSEcCtD
Testolactone—Discomfort—Methotrexate—breast cancer	4.16e-05	0.00147	CcSEcCtD
Testolactone—Drospirenone—AR—breast cancer	4.04e-05	0.0206	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—breast cancer	3.98e-05	0.00326	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—STK11—breast cancer	3.98e-05	0.00326	CbGpPWpGaD
Testolactone—Ill-defined disorder—Doxorubicin—breast cancer	3.98e-05	0.0014	CcSEcCtD
Testolactone—Nausea—Paclitaxel—breast cancer	3.93e-05	0.00138	CcSEcCtD
Testolactone—Discomfort—Epirubicin—breast cancer	3.9e-05	0.00137	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP3A4—breast cancer	3.88e-05	0.00318	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AR—breast cancer	3.87e-05	0.00317	CbGpPWpGaD
Testolactone—Malaise—Doxorubicin—breast cancer	3.87e-05	0.00136	CcSEcCtD
Testolactone—Anorexia—Methotrexate—breast cancer	3.85e-05	0.00136	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP3A4—breast cancer	3.83e-05	0.00314	CbGpPWpGaD
Testolactone—CYP19A1—Biological oxidations—CYP1B1—breast cancer	3.82e-05	0.00313	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	3.81e-05	0.00312	CbGpPWpGaD
Testolactone—CYP19A1—FSH signaling pathway—AKT1—breast cancer	3.8e-05	0.00312	CbGpPWpGaD
Testolactone—Oedema—Epirubicin—breast cancer	3.78e-05	0.00133	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1B1—breast cancer	3.76e-05	0.00308	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—breast cancer	3.68e-05	0.00302	CbGpPWpGaD
Testolactone—Danazol—PGR—breast cancer	3.67e-05	0.0187	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—NCOA1—breast cancer	3.64e-05	0.00298	CbGpPWpGaD
Testolactone—Paraesthesia—Methotrexate—breast cancer	3.63e-05	0.00128	CcSEcCtD
Testolactone—Discomfort—Doxorubicin—breast cancer	3.61e-05	0.00127	CcSEcCtD
Testolactone—Anorexia—Epirubicin—breast cancer	3.6e-05	0.00127	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ABL1—breast cancer	3.6e-05	0.00295	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—breast cancer	3.6e-05	0.00295	CbGpPWpGaD
Testolactone—Fluoxymesterone—SHBG—breast cancer	3.59e-05	0.0183	CrCbGaD
Testolactone—Vomiting—Docetaxel—breast cancer	3.56e-05	0.00125	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—breast cancer	3.53e-05	0.00289	CbGpPWpGaD
Testolactone—Spironolactone—PGR—breast cancer	3.51e-05	0.0179	CrCbGaD
Testolactone—Decreased appetite—Methotrexate—breast cancer	3.51e-05	0.00124	CcSEcCtD
Testolactone—Oedema—Doxorubicin—breast cancer	3.5e-05	0.00123	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—SMAD4—breast cancer	3.49e-05	0.00286	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	3.46e-05	0.00284	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	3.46e-05	0.00284	CbGpPWpGaD
Testolactone—Pain—Methotrexate—breast cancer	3.46e-05	0.00122	CcSEcCtD
Testolactone—Vomiting—Capecitabine—breast cancer	3.45e-05	0.00121	CcSEcCtD
Testolactone—Danazol—SHBG—breast cancer	3.43e-05	0.0175	CrCbGaD
Testolactone—Paraesthesia—Epirubicin—breast cancer	3.4e-05	0.00119	CcSEcCtD
Testolactone—Testosterone Propionate—AR—breast cancer	3.39e-05	0.0173	CrCbGaD
Testolactone—Drospirenone—BCHE—breast cancer	3.38e-05	0.0172	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—COMT—breast cancer	3.34e-05	0.00273	CbGpPWpGaD
Testolactone—Anorexia—Doxorubicin—breast cancer	3.34e-05	0.00117	CcSEcCtD
Testolactone—Nausea—Docetaxel—breast cancer	3.33e-05	0.00117	CcSEcCtD
Testolactone—Feeling abnormal—Methotrexate—breast cancer	3.33e-05	0.00117	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTP1—breast cancer	3.32e-05	0.00272	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BAX—breast cancer	3.3e-05	0.0027	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—COMT—breast cancer	3.29e-05	0.0027	CbGpPWpGaD
Testolactone—Decreased appetite—Epirubicin—breast cancer	3.29e-05	0.00116	CcSEcCtD
Testolactone—Spironolactone—SHBG—breast cancer	3.28e-05	0.0167	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HADHB—breast cancer	3.28e-05	0.00269	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—E2F1—breast cancer	3.28e-05	0.00268	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTP1—breast cancer	3.27e-05	0.00268	CbGpPWpGaD
Testolactone—Pain—Epirubicin—breast cancer	3.23e-05	0.00114	CcSEcCtD
Testolactone—Nausea—Capecitabine—breast cancer	3.22e-05	0.00113	CcSEcCtD
Testolactone—Fluoxymesterone—AR—breast cancer	3.15e-05	0.016	CrCbGaD
Testolactone—Paraesthesia—Doxorubicin—breast cancer	3.14e-05	0.00111	CcSEcCtD
Testolactone—Feeling abnormal—Epirubicin—breast cancer	3.12e-05	0.0011	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—GSTM1—breast cancer	3.05e-05	0.0025	CbGpPWpGaD
Testolactone—Decreased appetite—Doxorubicin—breast cancer	3.04e-05	0.00107	CcSEcCtD
Testolactone—Estrone—ESR2—breast cancer	3.03e-05	0.0154	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—GSTM1—breast cancer	3.01e-05	0.00247	CbGpPWpGaD
Testolactone—Danazol—AR—breast cancer	3.01e-05	0.0153	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3e-05	0.00246	CbGpPWpGaD
Testolactone—Pain—Doxorubicin—breast cancer	2.99e-05	0.00105	CcSEcCtD
Testolactone—Betamethasone—PGR—breast cancer	2.99e-05	0.0152	CrCbGaD
Testolactone—Methyltestosterone—SHBG—breast cancer	2.9e-05	0.0148	CrCbGaD
Testolactone—CYP19A1—Biological oxidations—CYP1A1—breast cancer	2.89e-05	0.00237	CbGpPWpGaD
Testolactone—Feeling abnormal—Doxorubicin—breast cancer	2.88e-05	0.00101	CcSEcCtD
Testolactone—Spironolactone—AR—breast cancer	2.88e-05	0.0147	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MMP1—breast cancer	2.88e-05	0.00236	CbGpPWpGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP1A1—breast cancer	2.85e-05	0.00234	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDK2—breast cancer	2.83e-05	0.00232	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	2.79e-05	0.00229	CbGpPWpGaD
Testolactone—Estrone—SHBG—breast cancer	2.76e-05	0.0141	CrCbGaD
Testolactone—Estrone—CYP1B1—breast cancer	2.76e-05	0.0141	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	2.7e-05	0.00221	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ATM—breast cancer	2.68e-05	0.0022	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDK4—breast cancer	2.67e-05	0.00219	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—breast cancer	2.66e-05	0.00218	CbGpPWpGaD
Testolactone—Exemestane—CYP3A4—breast cancer	2.57e-05	0.0131	CrCbGaD
Testolactone—Vomiting—Methotrexate—breast cancer	2.57e-05	0.000904	CcSEcCtD
Testolactone—Progesterone—CYP17A1—breast cancer	2.56e-05	0.0131	CrCbGaD
Testolactone—Methyltestosterone—AR—breast cancer	2.54e-05	0.013	CrCbGaD
Testolactone—Danazol—CYP19A1—breast cancer	2.52e-05	0.0128	CrCbGaD
Testolactone—Triamcinolone—BCHE—breast cancer	2.5e-05	0.0127	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.49e-05	0.00204	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.46e-05	0.00201	CbGpPWpGaD
Testolactone—Fluoxymesterone—ESR1—breast cancer	2.42e-05	0.0124	CrCbGaD
Testolactone—Vomiting—Epirubicin—breast cancer	2.4e-05	0.000846	CcSEcCtD
Testolactone—Nausea—Methotrexate—breast cancer	2.4e-05	0.000844	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.4e-05	0.00197	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BRAF—breast cancer	2.36e-05	0.00194	CbGpPWpGaD
Testolactone—Dexamethasone—CYP17A1—breast cancer	2.35e-05	0.012	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—breast cancer	2.34e-05	0.00192	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SYNJ2—breast cancer	2.33e-05	0.00191	CbGpPWpGaD
Testolactone—Progesterone—ABCC1—breast cancer	2.32e-05	0.0119	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—RB1—breast cancer	2.32e-05	0.0019	CbGpPWpGaD
Testolactone—Danazol—ESR1—breast cancer	2.32e-05	0.0118	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—breast cancer	2.31e-05	0.0019	CbGpPWpGaD
Testolactone—Nausea—Epirubicin—breast cancer	2.25e-05	0.00079	CcSEcCtD
Testolactone—Vomiting—Doxorubicin—breast cancer	2.22e-05	0.000783	CcSEcCtD
Testolactone—CYP19A1—Metabolism—NDUFS3—breast cancer	2.16e-05	0.00177	CbGpPWpGaD
Testolactone—Methyltestosterone—CYP19A1—breast cancer	2.13e-05	0.0108	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.08e-05	0.0017	CbGpPWpGaD
Testolactone—Nausea—Doxorubicin—breast cancer	2.08e-05	0.000731	CcSEcCtD
Testolactone—Betamethasone—CYP19A1—breast cancer	2.05e-05	0.0105	CrCbGaD
Testolactone—CYP19A1—Metabolism—CHST9—breast cancer	2.03e-05	0.00167	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—breast cancer	2.01e-05	0.00165	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.99e-05	0.00163	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—breast cancer	1.98e-05	0.00162	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.93e-05	0.00158	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—COX11—breast cancer	1.93e-05	0.00158	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MTOR—breast cancer	1.93e-05	0.00158	CbGpPWpGaD
Testolactone—Dexamethasone—NOS2—breast cancer	1.91e-05	0.00975	CrCbGaD
Testolactone—Estrone—ABCG2—breast cancer	1.91e-05	0.00971	CrCbGaD
Testolactone—Progesterone—PGR—breast cancer	1.9e-05	0.0097	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.9e-05	0.00155	CbGpPWpGaD
Testolactone—Estrone—ESR1—breast cancer	1.87e-05	0.00952	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.84e-05	0.00151	CbGpPWpGaD
Testolactone—Budesonide—CYP3A4—breast cancer	1.78e-05	0.0091	CrCbGaD
Testolactone—Progesterone—SHBG—breast cancer	1.78e-05	0.00906	CrCbGaD
Testolactone—Progesterone—CYP1B1—breast cancer	1.78e-05	0.00906	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CASP3—breast cancer	1.77e-05	0.00145	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CDA—breast cancer	1.76e-05	0.00145	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SHMT1—breast cancer	1.76e-05	0.00145	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.74e-05	0.00143	CbGpPWpGaD
Testolactone—Dexamethasone—PGR—breast cancer	1.74e-05	0.00887	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—breast cancer	1.72e-05	0.00141	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.72e-05	0.00141	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—JUN—breast cancer	1.72e-05	0.00141	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—breast cancer	1.71e-05	0.0014	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLCO1B1—breast cancer	1.7e-05	0.00139	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A5—breast cancer	1.7e-05	0.00139	CbGpPWpGaD
Testolactone—Ciclesonide—CYP2D6—breast cancer	1.7e-05	0.00864	CrCbGaD
Testolactone—Testosterone—SHBG—breast cancer	1.68e-05	0.00857	CrCbGaD
Testolactone—Testosterone—CYP1B1—breast cancer	1.68e-05	0.00857	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—breast cancer	1.66e-05	0.00136	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.66e-05	0.00136	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—APRT—breast cancer	1.64e-05	0.00134	CbGpPWpGaD
Testolactone—Dexamethasone—CYP1B1—breast cancer	1.63e-05	0.00829	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.61e-05	0.00132	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.6e-05	0.00131	CbGpPWpGaD
Testolactone—Progesterone—AR—breast cancer	1.56e-05	0.00795	CrCbGaD
Testolactone—Drospirenone—PTGS2—breast cancer	1.56e-05	0.00794	CrCbGaD
Testolactone—CYP19A1—Metabolism—ANGPTL4—breast cancer	1.54e-05	0.00126	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ESRRA—breast cancer	1.54e-05	0.00126	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—breast cancer	1.5e-05	0.00123	CbGpPWpGaD
Testolactone—Estrone—CYP1A1—breast cancer	1.49e-05	0.00761	CrCbGaD
Testolactone—Testosterone—AR—breast cancer	1.47e-05	0.00751	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.47e-05	0.0012	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HADHB—breast cancer	1.46e-05	0.0012	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPI—breast cancer	1.46e-05	0.0012	CbGpPWpGaD
Testolactone—Ciclesonide—CYP3A4—breast cancer	1.45e-05	0.00742	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.4e-05	0.00115	CbGpPWpGaD
Testolactone—Methylprednisolone—CYP3A4—breast cancer	1.39e-05	0.00711	CrCbGaD
Testolactone—CYP19A1—Metabolism—ALDH7A1—breast cancer	1.39e-05	0.00114	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALDH1A1—breast cancer	1.39e-05	0.00114	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MYC—breast cancer	1.38e-05	0.00113	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—breast cancer	1.35e-05	0.00111	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PHGDH—breast cancer	1.34e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NME1—breast cancer	1.34e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—UMPS—breast cancer	1.34e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—FHL2—breast cancer	1.34e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ADSL—breast cancer	1.34e-05	0.0011	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HPSE—breast cancer	1.31e-05	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—BRIP1—breast cancer	1.31e-05	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—LDHB—breast cancer	1.31e-05	0.00107	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—breast cancer	1.28e-05	0.00105	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HMMR—breast cancer	1.24e-05	0.00102	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCC1—breast cancer	1.24e-05	0.00102	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA3—breast cancer	1.24e-05	0.00102	CbGpPWpGaD
Testolactone—Testosterone—CYP19A1—breast cancer	1.23e-05	0.00629	CrCbGaD
Testolactone—CYP19A1—Metabolism—PPARGC1B—breast cancer	1.2e-05	0.000986	CbGpPWpGaD
Testolactone—Progesterone—ESR1—breast cancer	1.2e-05	0.00612	CrCbGaD
Testolactone—Dexamethasone—CYP19A1—breast cancer	1.19e-05	0.00608	CrCbGaD
Testolactone—Danazol—CYP3A4—breast cancer	1.18e-05	0.00603	CrCbGaD
Testolactone—Triamcinolone—CYP3A4—breast cancer	1.18e-05	0.006	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.17e-05	0.00096	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.17e-05	0.00096	CbGpPWpGaD
Testolactone—Methylprednisolone—ABCB1—breast cancer	1.16e-05	0.00592	CrCbGaD
Testolactone—Testosterone—ABCG2—breast cancer	1.16e-05	0.00591	CrCbGaD
Testolactone—Triamcinolone—PTGS2—breast cancer	1.15e-05	0.00587	CrCbGaD
Testolactone—CYP19A1—Metabolism—CA9—breast cancer	1.14e-05	0.000931	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA4—breast cancer	1.14e-05	0.000931	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	1.14e-05	0.000931	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.12e-05	0.000919	CbGpPWpGaD
Testolactone—Dexamethasone—ABCG2—breast cancer	1.12e-05	0.00571	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.11e-05	0.00091	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPX2—breast cancer	1.11e-05	0.000907	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA2—breast cancer	1.11e-05	0.000907	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SULT1A1—breast cancer	1.09e-05	0.000896	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GPX4—breast cancer	1.09e-05	0.000896	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—IDH1—breast cancer	1.07e-05	0.000876	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTA1—breast cancer	1.07e-05	0.000876	CbGpPWpGaD
Testolactone—Prednisone—CYP3A4—breast cancer	1.07e-05	0.00544	CrCbGaD
Testolactone—CYP19A1—Metabolism—NAT2—breast cancer	1.06e-05	0.000866	CbGpPWpGaD
Testolactone—Methyltestosterone—CYP3A4—breast cancer	9.98e-06	0.00509	CrCbGaD
Testolactone—Prednisolone—CYP3A4—breast cancer	9.83e-06	0.00501	CrCbGaD
Testolactone—Betamethasone—CYP3A4—breast cancer	9.63e-06	0.00491	CrCbGaD
Testolactone—Progesterone—CYP1A1—breast cancer	9.6e-06	0.00489	CrCbGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	9.59e-06	0.000786	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.55e-06	0.000783	CbGpPWpGaD
Testolactone—Estrone—CYP3A4—breast cancer	9.52e-06	0.00486	CrCbGaD
Testolactone—Betamethasone—PTGS2—breast cancer	9.43e-06	0.00481	CrCbGaD
Testolactone—Spironolactone—ABCB1—breast cancer	9.42e-06	0.00481	CrCbGaD
Testolactone—Prednisone—ALB—breast cancer	9.31e-06	0.00474	CrCbGaD
Testolactone—CYP19A1—Metabolism—DPYD—breast cancer	9.26e-06	0.000759	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MED12—breast cancer	9.26e-06	0.000759	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALDOA—breast cancer	9.12e-06	0.000747	CbGpPWpGaD
Testolactone—Testosterone—CYP1A1—breast cancer	9.07e-06	0.00463	CrCbGaD
Testolactone—Prednisone—ABCB1—breast cancer	8.88e-06	0.00453	CrCbGaD
Testolactone—CYP19A1—Metabolism—NCOA3—breast cancer	8.85e-06	0.000725	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A2—breast cancer	8.79e-06	0.00072	CbGpPWpGaD
Testolactone—Dexamethasone—CYP1A1—breast cancer	8.78e-06	0.00448	CrCbGaD
Testolactone—Methyltestosterone—ALB—breast cancer	8.71e-06	0.00444	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.7e-06	0.000713	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ABCG2—breast cancer	8.61e-06	0.000706	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CPT1A—breast cancer	8.61e-06	0.000706	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTR—breast cancer	8.61e-06	0.000706	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HPGDS—breast cancer	8.44e-06	0.000692	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HBA1—breast cancer	8.39e-06	0.000688	CbGpPWpGaD
Testolactone—Estrone—ALB—breast cancer	8.31e-06	0.00424	CrCbGaD
Testolactone—CYP19A1—Metabolism—GSTT1—breast cancer	8.19e-06	0.000671	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ACHE—breast cancer	8.19e-06	0.000671	CbGpPWpGaD
Testolactone—Prednisolone—ABCB1—breast cancer	8.19e-06	0.00417	CrCbGaD
Testolactone—Betamethasone—ABCB1—breast cancer	8.02e-06	0.00409	CrCbGaD
Testolactone—Estrone—ABCB1—breast cancer	7.93e-06	0.00404	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP17A1—breast cancer	7.75e-06	0.000635	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS1—breast cancer	7.67e-06	0.000629	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ENO1—breast cancer	7.67e-06	0.000629	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.65e-06	0.000627	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.55e-06	0.000619	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP2D6—breast cancer	7.53e-06	0.000617	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA2—breast cancer	7.39e-06	0.000605	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—FASN—breast cancer	7.17e-06	0.000587	CbGpPWpGaD
Testolactone—Progesterone—CYP2D6—breast cancer	7.14e-06	0.00364	CrCbGaD
Testolactone—CYP19A1—Metabolism—BCHE—breast cancer	7.14e-06	0.000585	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC5A5—breast cancer	7.05e-06	0.000578	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SLC2A1—breast cancer	6.81e-06	0.000558	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NQO1—breast cancer	6.81e-06	0.000558	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.67e-06	0.000546	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP3A4—breast cancer	6.64e-06	0.000544	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.6e-06	0.000541	CbGpPWpGaD
Testolactone—Dexamethasone—CYP2D6—breast cancer	6.53e-06	0.00333	CrCbGaD
Testolactone—CYP19A1—Metabolism—CYP1B1—breast cancer	6.53e-06	0.000535	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—HSP90AA1—breast cancer	6.4e-06	0.000525	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOA1—breast cancer	6.23e-06	0.00051	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—STK11—breast cancer	6.14e-06	0.000503	CbGpPWpGaD
Testolactone—Progesterone—CYP3A4—breast cancer	6.13e-06	0.00312	CrCbGaD
Testolactone—Testosterone—CYP3A4—breast cancer	5.79e-06	0.00295	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.76e-06	0.000472	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—COMT—breast cancer	5.7e-06	0.000467	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTP1—breast cancer	5.68e-06	0.000465	CbGpPWpGaD
Testolactone—Dexamethasone—CYP3A4—breast cancer	5.6e-06	0.00286	CrCbGaD
Testolactone—CYP19A1—Metabolism—HMOX1—breast cancer	5.6e-06	0.000459	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ITPR1—breast cancer	5.59e-06	0.000458	CbGpPWpGaD
Testolactone—Dexamethasone—PTGS2—breast cancer	5.49e-06	0.0028	CrCbGaD
Testolactone—CYP19A1—Metabolism—ABCB1—breast cancer	5.37e-06	0.00044	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—TYMS—breast cancer	5.28e-06	0.000433	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—GSTM1—breast cancer	5.22e-06	0.000428	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NCOR1—breast cancer	5.22e-06	0.000428	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PLA2G4A—breast cancer	5.22e-06	0.000428	CbGpPWpGaD
Testolactone—Progesterone—ABCB1—breast cancer	5.1e-06	0.0026	CrCbGaD
Testolactone—Testosterone—ALB—breast cancer	5.05e-06	0.00258	CrCbGaD
Testolactone—CYP19A1—Metabolism—GPX1—breast cancer	5e-06	0.000409	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP1A1—breast cancer	4.95e-06	0.000405	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ERCC2—breast cancer	4.91e-06	0.000402	CbGpPWpGaD
Testolactone—Testosterone—ABCB1—breast cancer	4.82e-06	0.00246	CrCbGaD
Testolactone—Dexamethasone—ABCB1—breast cancer	4.66e-06	0.00238	CrCbGaD
Testolactone—CYP19A1—Metabolism—MTHFR—breast cancer	4.61e-06	0.000378	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CAV1—breast cancer	4.25e-06	0.000349	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.06e-06	0.000333	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CG—breast cancer	3.87e-06	0.000317	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CD—breast cancer	3.41e-06	0.000279	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—ALB—breast cancer	3.36e-06	0.000276	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NOS3—breast cancer	3.22e-06	0.000264	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CB—breast cancer	2.97e-06	0.000243	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTGS2—breast cancer	2.94e-06	0.000241	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTEN—breast cancer	2.56e-06	0.00021	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CA—breast cancer	1.81e-06	0.000148	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKT1—breast cancer	1.48e-06	0.000121	CbGpPWpGaD
